Radiation dose ≥54 Gy and CA 19–9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation

BACKGROUND: Unresectable pancreatic cancer (UPC) has low survival. With improving staging techniques and systemic therapy, local control in patients without metastatic disease may have increasing importance. We investigated whether the radiation dose used in chemoradiation (CRT) as definitive treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Golden, Daniel W, Novak, Caroline J, Minsky, Bruce D, Liauw, Stanley L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527337/
https://www.ncbi.nlm.nih.gov/pubmed/22974515
http://dx.doi.org/10.1186/1748-717X-7-156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527337/
https://www.ncbi.nlm.nih.gov/pubmed/22974515
http://dx.doi.org/10.1186/1748-717X-7-156

Ejemplares similares